Navigation Links
Columbia research lifts major hurdle to gene therapy for cancer

Researchers at Columbia University Medical Center have discovered a way to overcome one of the major hurdles in gene therapy for cancer: its tendency to kill normal cells in the process of eradicating cancer cells. In a new study published in the Jan. 25 issue of the Proceedings of the National Academy of Sciences (PNAS), the researchers demonstrated that the technique works by incorporating it into a specially designed virus. The virus eradicated prostate cancer cells in the lab and in animals while leaving normal cells unscathed.

Gene therapy based on the new technique should also be effective for a wide range of tumors - such as ovarian, breast, brain (glioma), skin (melanoma) and colon cancer - because the virus is constructed to exploit a characteristic of all solid cancers. "What's exciting is we may now be able to design a therapy that will seek out and destroy only cancer cells," said the study's senior author, Paul B. Fisher, Ph.D., professor of clinical pathology and Michael and Stella Chernow Urological Cancer Research Scientist at Columbia University Medical Center. "We hope it will be particularly powerful in eradicating metastases that we can't see and that can't be eliminated by surgery or radiation. Gene therapy, especially for cancer, is really starting to make a comeback." The virus's selectivity for cancer cells is based on two molecules called PEA-3 and AP-1 that, the researchers found, are usually abundant inside cancer cells. Both of the molecules flip a switch (called PEG) that turns on the production of a cancer-inhibiting protein uniquely in tumor cells. The researchers say the PEG switch can be exploited to produce gene therapies that will only kill cancer cells even if the therapy enters normal cells. As an example, the researchers constructed an adenovirus that carries the PEG switch and a toxic protein. The switch and the protein were connected to each other so that the deadly protein is only unleashed inside cancer cells when the
'"/>

Source:Eurekalert


Page: 1 2

Related biology news :

1. Columbia study shows widely used artery clearing device does not help patients during heart attack
2. Columbia scientists develop cancer terminator viruses
3. Contaminants linked to sturgeon decline in Columbia river
4. Columbia University licenses next-generation DNA sequencing technology
5. New bird discovered on unexplored Columbian mountain
6. Columbia scientists determine 3-dimensional structure of cells fuel gauge
7. U of M researcher examines newly emerging deadly disease
8. NYU researchers simulate molecular biological clock
9. First atlas of key brain genes could speed research on cancer, neurological diseases
10. New research questions basic tenet of neuron function
11. Vital step in cellular migration described by UCSD medical researchers

Post Your Comments:
(Date:11/5/2009)...e University have developed synthetic molecules ca...IV and HIV-infected cells, as well as to prostate ...the Journal of the American Chemical Society , co... diseases. , The molecules called "antibody-re...body-recruiting molecule targeting prostate cancer...
(Date:11/4/2009)...ence) , United States Using Less Water Today ...t did 35 years ago, despite a 30 percent populatio...butable to alternative cooling methods at power pl...ing to the latest USGS water use report, nearly ha...cooling thermoelectric power plants. Irrigation ac...
(Date:11/4/2009)... turns out, hold the power to help militaries and ...ean up toxic waste on test sites. , Compounds kn... back in World War II and have been used in milita...unds are often used to propel tank shells and act ...h increased knowledge of their environmentally har...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Genomic research will enable greener cleanup of military explosive test sites 2ProFibrix Initiates Phase II Clinical Trial of its Lead Topical Hemostat Product Fibrocaps 28TM 29 4611 1Congress Appeals to Obama Administration Thailand 3A Stop Hmong Returns to Laos 49312 1Congress Appeals to Obama Administration Thailand 3A Stop Hmong Returns to Laos 49312 2Common fish species has human ability to learn 8889 1Common fish species has human ability to learn 8889 2Common fish species has human ability to learn 8889 3
...rug Discovery (LSCDD), Singapore,s National Neuros...e for Clinical Sciences (SICS), have teamed up to ...em cells. , NNI is one of the institutions of Si...ingapore. LSCDD, a wholly owned subsidiary of the ...Company has recently expanded its facility at the ...
..., methyl bromide (MB) has been the foundation for ...trawberries. MB, classified as a Class I stratosph... since 2005, but is still being used in strawberry...wberry production is important to California,s eco...ction. In 2006, the fruit harvest yielded a value ...
... Mycotoxin Research have signed an agreement to pu...h , the official journal of the Society. Aimed at...roducing industry, the journal deals with all topi...oduced by molds. The first issue will appear in M...s and review articles in Mycotoxin Research addr...
Other Biology News:Singapore research organisations team up to advance drug discovery using brain tumor stem cells 2Methyl bromide alternatives for California strawberry nurseries 2Mycotoxin Research joins Springer's life sciences journals program 2
(Date:11/6/2009)..., TORONTO, Nov. 6 /PRNewswire-FirstCall/ - Microb... that it has re-filed the Form 52-109F1 Certificat... Executive Officer and James Long, the Chief Finan...January 12, 2009 in connection with the annual aud...mber 30, 2008. ,, The Company initially filed t...
(Date:11/6/2009)..., VIENNA, Austria, November 6 ...zing, manufacturing, and marketing enzymes for the...ered into a research,agreement with Bio Sidus, the...a. , The agreement gives EUCODIS Bioscien... interest - to Bio Sidus, proprietary collection o...
(Date:11/6/2009)..., HAYWARD, Calif., Nov. 6 Intarci...oday on its ITCA 650 (DUROS® continuous deliv...e 2 diabetes at the Ninth Annual Diabetes Technolo...p://www.newscom.com/cgi-bin/prnh/20050301/SFTU126L...Exenatide Via ITCA 650 Lowers Plasma Glucose, HbA1...
(Date:11/5/2009)..., WELLINGTON, Colo., Nov. 5 The e... towns in the western U.S. This rare carnivore fe...usceptible to plague and often entire population d...ife Service (FWS) has implemented a ferret breedin...ferrets into their formerly native habitat. Unfor...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2
.... 28 XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB ...009 it received a Staff Determination Letter (the ...notifying the Company that the staff of Nasdaq,s L... its discretionary authority under Nasdaq Marketpl...ory Shares ("ADRs") would be delisted from Nasdaq....
...Clinical Force, a web based CTMS (Clinical Trial M...lected its solution. "We have deployed visit ...line client currently. Future phases of our projec...capture and possibly our financial system, as well...tem that will give us clear advantages in the serv...
...With the pre-registration period for the European ...ization and restriction of Chemicals) having ended...business segment of SAFC(R), a member of the Sigma...ive research into which products would be required...ed its capacity to supply the products deemed crit...
Other Biology Technology:AAIPharma Deploys Clinical Force CTMS (Clinical Trials Management System) 2AAIPharma Deploys Clinical Force CTMS (Clinical Trials Management System) 3SAFC Adopts Targeted Approach to Reach Pre-Registration 2SAFC Adopts Targeted Approach to Reach Pre-Registration 3SAFC Adopts Targeted Approach to Reach Pre-Registration 4
Chicken Anti-Human QPRT Polyclonal Antibody, Unconjugated from ProSci, Inc
HRP Protein Marker Detection Pack from New England Biolabs
Mouse Anti-Y14 Monoclonal Antibody, Unconjugated, Clone 4C4 from Abcam
Rabbit Anti-Human JMJD2B Polyclonal Antibody, Unconjugated from ProSci, Inc
Biology Products: